WHO ICTRP trial
18F-Fluorothymidine Positron Emission Tomography as an early predictor of…
EUCTR2010-020472-34-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-020472-34-IT |
|---|---|
| Public title | 18F-Fluorothymidine Positron Emission Tomography as an early predictor of response to neoadjuvant therapy in patients with locally advanced breast carcinoma - ND |
| Scientific title | 18F-Fluorothymidine Positron Emission Tomography as an early predictor of response to neoadjuvant therapy in patients with locally advanced breast carcinoma - ND |
| Primary sponsor | ISTITUTO EUROPEO DI ONCOLOGIA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Breast carcinoma classified as cT1b,c, T2, T3, or cT4 a-c, cN0-2, N3, M0 MedDRA version: 9.1 Level: HLT Classification code 10006289 |
| Interventions | Product Name: 3-DE18F-FLT (3`-deoxy-3`-[18F]fluorothymidine) Pharmaceutical Form: Solution for injection Other descriptive name: 18F-FLT (3`-deoxy-3`-[18F]fluorothymidine) Concentration unit: MBq/ml megabecquerel(s)/millilitre Concentration… |
| Registration date | Dec 24, 2010 |
| Secondary IDs | IEO S542/310 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: